Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Snakes: Myth busting with Melbourne Zoo
As temperatures rise, snakes are emerging from a period of reduced activity during winter seeking food and mates. Snakes may ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:44 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Chris Zeiher, Lonely Planet: Travel trends here to stay!
Skyscanner has released there annual survey report where 75% of Aussie travellers believe "holidays build resilience and strength to handle ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 14:27 — 19.8MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Lauren Rosewarne: Doom Spending
Americans are feeling anxious — so they’re ‘doom spending'. What exactly is "doom spending," and how did this trend emerge? ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 10:56 — 15.0MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS